1. Açık Erişim@BUU
  2. İndeksli Yayınlar
  3. Web of Science
Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/23941
Tüm üstveri kaydı
Dublin Core AlanıDeğerDil
dc.date.accessioned2022-01-10T05:35:32Z-
dc.date.available2022-01-10T05:35:32Z-
dc.date.issued2001-09-
dc.identifier.citationİşbil, B. N. vd. (2001). "A central link between angiotensinergic and cholinergic systems; role of vasopressin". Peptides, 22(9), 1415-1420.en_US
dc.identifier.issn0196-9781-
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0196978101004788-
dc.identifier.urihttps://doi.org/10.1016/S0196-9781(01)00478-8-
dc.identifier.urihttp://hdl.handle.net/11452/23941-
dc.description.abstractParticipation of central cholinergic system in the effects of intracerebroventricular (i.c.v.) injection of angiotensin II (Ana II) on blood pressure and heart rate was studied in conscious, freely moving rats, Ang II dose-dependently increased blood pressure and decreased heart rate. Both atropine and mecamylamine (i.c.v.) pretreatments prevented the cardiovascular effects of Ana II. Pretreatment with a vasopressin V-1 antagonist also prevented the cardiovascular responses to Ang II. Our data suggest that the central pressor effect of Ang II is mediated in part by central acetylcholine via both muscarinic and nicotinic receptors, and vasopressin participates in this effect through V-1 receptors.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCholinergic systemen_US
dc.subjectAng IIen_US
dc.subjectBlood pressureen_US
dc.subjectHeart rateen_US
dc.subjectIntracerebroventricularen_US
dc.subjectV1 antagonisten_US
dc.subjectPressoren_US
dc.subjectResponsesen_US
dc.subjectReleaseen_US
dc.subjectInjectionen_US
dc.subjectCarbacholen_US
dc.subjectDrinkingen_US
dc.subjectBrainen_US
dc.subjectBiochemistry & molecular biologyen_US
dc.subjectEndocrinology & metabolismen_US
dc.subjectPharmacology & pharmacyen_US
dc.subject.meshAngiotensin IIen_US
dc.subject.meshAnimalsen_US
dc.subject.meshSympathetic nervous systemen_US
dc.subject.meshBrainen_US
dc.subject.meshReceptors, vasopressinen_US
dc.subject.meshAtropinetr_TR
dc.subject.meshBlood pressuretr_TR
dc.subject.meshConsciousnesstr_TR
dc.subject.meshDose-response relationship, drugtr_TR
dc.subject.meshDrug Interactionsen_US
dc.subject.meshTime factorsen_US
dc.subject.meshHeart rateen_US
dc.subject.meshInjections, intraventricularen_US
dc.subject.meshInjections, intra-arterialen_US
dc.subject.meshMaleen_US
dc.subject.meshMecamylamineen_US
dc.subject.meshMuscarinic antagonistsen_US
dc.subject.meshNicotinic antagonistsen_US
dc.subject.meshRatsen_US
dc.subject.meshRats, sprague-dawleyen_US
dc.subject.meshReceptors, mmuscarinicen_US
dc.subject.meshReceptors, nicotinicen_US
dc.subject.meshVasopressinsen_US
dc.titleA central link between angiotensinergic and cholinergic systems; role of vasopressinen_US
dc.typeArticleen_US
dc.identifier.wos000170561200008tr_TR
dc.identifier.scopus2-s2.0-0034888525tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Fizyoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0003-0863-1547tr_TR
dc.identifier.startpage1415tr_TR
dc.identifier.endpage1420tr_TR
dc.identifier.volume22tr_TR
dc.identifier.issue9tr_TR
dc.relation.journalPeptidesen_US
dc.contributor.buuauthorİşbil, Büyükcoşkun Naciye-
dc.contributor.buuauthorGüleç, Güliz Uyar-
dc.contributor.buuauthorÖzlük, Kasım-
dc.contributor.researcheridAAH-1692-2021tr_TR
dc.contributor.researcheridC-5730-2015tr_TR
dc.identifier.pubmed11514022tr_TR
dc.subject.wosBiochemistry & molecular biologyen_US
dc.subject.wosEndocrinology & metabolismen_US
dc.subject.wosPharmacology & pharmacyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ2 (Biochemistry & molecular biology)en_US
dc.wos.quartileQ2 (Pharmacology & pharmacy)en_US
dc.contributor.scopusid6603128152tr_TR
dc.contributor.scopusid6602752303tr_TR
dc.contributor.scopusid6602676331tr_TR
dc.subject.scopusPregnanolone; Orexins; Scotophaseen_US
dc.subject.emtreeAcetylcholineen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeAnimal experimenten_US
dc.subject.emtreeCardiovascular effecten_US
dc.subject.emtreeCardiovascular responseen_US
dc.subject.emtreeCholinergic systemen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeBlood pressureen_US
dc.subject.emtreeDose responseen_US
dc.subject.emtreeHeart rateen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeRaten_US
dc.subject.emtreeAngiotensinen_US
dc.subject.emtreeAtropineen_US
dc.subject.emtreeMecamylamineen_US
dc.subject.emtreeMuscarinic receptoren_US
dc.subject.emtreeNicotinic receptoren_US
dc.subject.emtreeVasopressinen_US
dc.subject.emtreeVasopressin receptor antagonisten_US
dc.subject.emtreeVasopressin V1 receptoren_US
Koleksiyonlarda Görünür:Scopus
Web of Science

Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
Kısa Öğe Kaydını Göster İstatistikler


DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.